Home › Encyclopedia › Albiglutide: Research Status, Structure, and Trial Data
Research / Unapproved

Albiglutide: Research Status, Structure, and Trial Data

Molecular formulaC148H223N39O46
Molecular weight3284.6 g/mol
Registered trials39
PubChem CID122173812

What Albiglutide Is

Albiglutide is a large peptide compound with the molecular formula C148H223N39O46 and a molecular weight of about 3284.6 daltons (PubChem CID 122173812). This monograph reflects unapproved research status: no active FDA product label is on file for albiglutide in the data reviewed here, so no approved indication, dosing, or mechanism claim can be drawn from a label. Any information below comes strictly from registered trial records, not from labeling or efficacy claims.

Trial Footprint

Public registries list 39 clinical trials involving albiglutide. The sample of records available includes early-phase studies focused on pharmacology rather than treatment outcomes. One trial examined the pharmacokinetics of albiglutide in normal subjects and those with renal impairment (NCT00938158, completed). Another compared two albiglutide drug products for bioequivalence in healthy adults (NCT02660736, completed). A third assessed a drug interaction between albiglutide and warfarin (NCT01147731, completed). These records describe study design and status only, not benefit or safety conclusions.

FAQ

Is albiglutide FDA approved?
No active approved label for albiglutide is reflected in this data. It is presented here strictly as a research compound based on registered trial records.
What is albiglutide chemically?
Albiglutide is a large peptide with the molecular formula C148H223N39O46 and a molecular weight of roughly 3284.6 daltons. It is cataloged in PubChem under CID 122173812.
How many clinical trials have studied albiglutide?
Public registries list 39 trials involving albiglutide. Available sample records include early-phase studies on pharmacokinetics, bioequivalence, and drug interactions.
What did the albiglutide trials examine?
Sample trials looked at pharmacokinetics in subjects with normal versus impaired renal function, bioequivalence between two drug products, and a potential interaction with warfarin. All three sample trials are completed.
Are there reported side effects for albiglutide?
No adverse event report data was available in this dataset, so no side effect summary can be provided here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 122173812 ClinicalTrials.gov

Updated 2026-09-19